Account
Inquiry
QSC Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. This compound demonstrates superior efficacy in glucose control and weight management studies compared to selective GLP-1 receptor agonists.
The qsc tirzepatide molecule exhibits greater affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique dual mechanism has shown promising results in preclinical research for metabolic disorders. The compound mimics the actions of natural GIP at the GIP receptor while providing sustained GLP-1 receptor activation.
Our qsc tirzepatide is supplied as high purity white powder (>98%) with comprehensive analytical documentation. The product is carefully packaged to ensure stability and is shipped under appropriate conditions for research use. Proper storage at -20°C is recommended for long-term preservation.
As with all research compounds, this qsc tirzepatide product is intended solely for laboratory research purposes. It is not for human consumption, diagnostic use, or therapeutic application. Researchers should handle all materials according to appropriate laboratory safety protocols.
